Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease
Authors
Keywords
-
Journal
MOLECULAR BIOLOGY REPORTS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-28
DOI
10.1007/s11033-021-06512-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of Atabecestat (JNJ-54861911): A Thiazine-Based β-Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor Advanced to the Phase 2b/3 EARLY Clinical Trial
- (2021) Yuji Koriyama et al. JOURNAL OF MEDICINAL CHEMISTRY
- Stem cells Therapies in Alzheimer's disease: applications for disease modeling
- (2021) Zizhen Si et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Coumarin linked heterocyclic hybrids: A promising approach to develop multi target drugs for Alzheimer's disease
- (2021) Asif Husain et al. JOURNAL OF MOLECULAR STRUCTURE
- Early response monitoring of neoadjuvant chemotherapy using [18F]FDG PET can predict the clinical outcome of extremity osteosarcoma
- (2020) Inki Lee et al. EJNMMI Research
- Inflammation in Traumatic Brain Injury
- (2020) Teodor T. Postolache et al. JOURNAL OF ALZHEIMERS DISEASE
- Alzheimer’s Disease-Like Neurodegeneration in Porphyromonas gingivalis Infected Neurons with Persistent Expression of Active Gingipains
- (2020) Ursula Haditsch et al. JOURNAL OF ALZHEIMERS DISEASE
- A Perspective on Multi-target Drugs for Alzheimer’s Disease
- (2020) Ondrej Benek et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer’s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study
- (2020) Gerald Novak et al. Alzheimers Research & Therapy
- Epigallocatechin-3-gallate Alleviates Cognitive Deficits in APP/PS1 Mice
- (2020) Jian Bao et al. Current Medical Science
- Effects of Chronic Masitinib Treatment in APPPS1dE9 Transgenic Mice Modeling Alzheimer’s Disease
- (2020) Tengfei Li et al. JOURNAL OF ALZHEIMERS DISEASE
- Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval
- (2020) Martin Tolar et al. Alzheimers Research & Therapy
- Repurposed agents in the Alzheimer’s disease drug development pipeline
- (2020) Justin Bauzon et al. Alzheimers Research & Therapy
- Stem cell therapy for Alzheimer's disease
- (2020) Xin-Yu Liu et al. World Journal of Stem Cells
- COR388, a novel gingipain inhibitor, decreases fragmentation of APOE in the central nervous system of Alzheimer’s disease patients
- (2020) Debasish Raha et al. Alzheimers & Dementia
- Combating COVID-19: The role of drug repurposing and medicinal plants
- (2020) Shah A. Khan et al. Journal of Infection and Public Health
- In vivo synaptic density imaging with 11C-UCB-J detects treatment effects of saracatinib (AZD0530) in a mouse model of Alzheimer’s disease.
- (2019) Takuya Toyonaga et al. JOURNAL OF NUCLEAR MEDICINE
- New therapeutic targeting of Alzheimer’s disease with the potential use of proline-rich polypeptide complex to modulate an innate immune response - preliminary study
- (2019) Marta Sochocka et al. Journal of Neuroinflammation
- Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease
- (2019) Christopher H. van Dyck et al. JAMA Neurology
- Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer’s disease mortality
- (2019) Julián Benito-León et al. PLoS One
- Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease
- (2019) Robert Howard et al. JAMA Neurology
- Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice
- (2019) Miren Ettcheto et al. MOLECULAR NEUROBIOLOGY
- Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis
- (2019) Gregory Klein et al. Alzheimers Research & Therapy
- Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late-onset Alzheimer’s disease associated with obesity, metabolic syndrome, and type 2 diabetes
- (2019) Maria Elizabeth De Sousa Rodrigues et al. Alzheimers Research & Therapy
- Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease
- (2018) Alireza Atri et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment?
- (2018) Patrick Gavin Kehoe JOURNAL OF ALZHEIMERS DISEASE
- Alzheimer's disease research: the future of BACE inhibitors
- (2018) Talha Burki LANCET
- Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer's model
- (2018) Levi M. Smith et al. NEUROPHARMACOLOGY
- Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy
- (2018) Xiaohai Wang et al. PLoS One
- Stem cell therapies in neurology: the good, the bad and the unknown
- (2018) Louisa Lyon BRAIN
- Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain
- (2018) John A. Hey et al. CNS DRUGS
- Potential Enzymatic Targets in Alzheimer’s: A Comprehensive Review
- (2018) Jahangir Alam et al. CURRENT DRUG TARGETS
- The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
- (2018) Ulf Neumann et al. EMBO Molecular Medicine
- Tau Cleavage at D421 by Caspase-3 is Induced in Neurons and Astrocytes Infected with Herpes Simplex Virus Type 1
- (2018) Rodrigo Lerchundi et al. JOURNAL OF ALZHEIMERS DISEASE
- The Murine Version of BAN2401 (mAb158) Selectively Reduces Amyloid-β Protofibrils in Brain and Cerebrospinal Fluid of tg-ArcSwe Mice
- (2018) Stina Tucker et al. JOURNAL OF ALZHEIMERS DISEASE
- Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors
- (2018) Annachiara Gandini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cysteine-Independent Inhibition of Alzheimer's Disease-like Paired Helical Filament Assembly by Leuco-Methylthioninium (LMT)
- (2018) Youssra K. Al-Hilaly et al. JOURNAL OF MOLECULAR BIOLOGY
- Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study
- (2018) Maarten Timmers et al. Alzheimers Research & Therapy
- BACE1 Inhibitor MK-8931 Alters Formation but Not Stability of Dendritic Spines
- (2018) Tanja Blume et al. Frontiers in Aging Neuroscience
- Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial
- (2018) Brian Lawlor et al. PLOS MEDICINE
- A role for APP in Wnt signalling links synapse loss with β-amyloid production
- (2018) Christina Elliott et al. Translational Psychiatry
- New approaches for the treatment of Alzheimer’s disease
- (2018) Paul V. Fish et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Stem cell therapies for Alzheimerʼs disease
- (2018) Sheng-Min Wang et al. CURRENT OPINION IN PSYCHIATRY
- The association of multiple anti-hypertensive medication classes with Alzheimer’s disease incidence across sex, race, and ethnicity
- (2018) Douglas Barthold et al. PLoS One
- A review on protein misfolding, aggregation and strategies to prevent related ailments
- (2017) Tooba Naz Shamsi et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- New Therapeutic Targets in Alzheimer's Disease
- (2017) Horia Coman et al. International Journal of Gerontology
- Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial
- (2017) Gordon K. Wilcock et al. JOURNAL OF ALZHEIMERS DISEASE
- The Rationale and Design of the Reducing Pathology in Alzheimer’s Disease through Angiotensin TaRgeting (RADAR) Trial
- (2017) Patrick G. Kehoe et al. JOURNAL OF ALZHEIMERS DISEASE
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
- (2016) Eric R. Siemers et al. Alzheimers & Dementia
- Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments
- (2016) Tangui Maurice BEHAVIOURAL BRAIN RESEARCH
- Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease
- (2016) Mudasir Maqbool et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease
- (2016) Eameema Muntimadugu et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics
- (2016) Susanna Eketjäll et al. JOURNAL OF ALZHEIMERS DISEASE
- Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment
- (2016) Jaume Folch et al. NEURAL PLASTICITY
- Protein structures in Alzheimer's disease: The basis for rationale therapeutic design
- (2015) Laia Montoliu-Gaya et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Prospects of β-Secretase Inhibitors for the Treatment of Alzheimer’s Disease
- (2015) Arun K. Ghosh et al. ChemMedChem
- (−)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer׳s disease model mice by upregulating neprilysin expression
- (2015) Xiang Chang et al. EXPERIMENTAL CELL RESEARCH
- Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
- (2015) Eleonore Beurel et al. PHARMACOLOGY & THERAPEUTICS
- Synthesis, biological evaluation and molecular modeling study of novel tacrine–carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease
- (2014) Supatra Thiratmatrakul et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication
- (2014) William James Deardorff et al. Expert Review of Neurotherapeutics
- Increased CSF APPs- levels in patients with Alzheimer disease treated with acitretin
- (2014) K. Endres et al. NEUROLOGY
- Drug Repositioning Approaches for the Discovery of New Therapeutics for Alzheimer’s Disease
- (2014) Tae-Wan Kim Neurotherapeutics
- Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission
- (2014) Gretchen L. Snyder et al. PSYCHOPHARMACOLOGY
- Rho Kinase Inhibitor Fasudil Protects againstβ-Amyloid-Induced Hippocampal Neurodegeneration in Rats
- (2013) Yun Song et al. CNS Neuroscience & Therapeutics
- Medial ganglionic eminence–like cells derived from human embryonic stem cells correct learning and memory deficits
- (2013) Yan Liu et al. NATURE BIOTECHNOLOGY
- Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices
- (2013) Ratti Ram Sharma et al. TRANSFUSION
- The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice
- (2013) Marguerite Prior et al. Alzheimers Research & Therapy
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects
- (2012) Randy Dockens et al. CLINICAL PHARMACOKINETICS
- Roles of Glycogen Synthase Kinase 3 in Alzheimer’s Disease
- (2012) Zhiyou Cai et al. Current Alzheimer Research
- Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt–PCP–JNK pathway
- (2012) R Killick et al. MOLECULAR PSYCHIATRY
- Drug repositioning for Alzheimer's disease
- (2012) Anne Corbett et al. NATURE REVIEWS DRUG DISCOVERY
- Etazolate, an α-secretase activator, reduces neuroinflammation and offers persistent neuroprotection following traumatic brain injury in mice
- (2012) Eleni Siopi et al. NEUROPHARMACOLOGY
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current and future treatments for Alzheimer’s disease
- (2012) Konstantina G. Yiannopoulou et al. Therapeutic Advances in Neurological Disorders
- Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells
- (2011) Xinjian Liu et al. CELL RESEARCH
- ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches
- (2011) Julien Delrieu et al. JOURNAL OF NEUROCHEMISTRY
- The Genetics of Alzheimer Disease: Back to the Future
- (2010) Lars Bertram et al. NEURON
- Lithium Trial in Alzheimer's Disease
- (2009) Harald Hampel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial
- (2008) Gordon K Wilcock et al. LANCET NEUROLOGY
- Glutamatergic Approaches to the Treatment of Cognitive and Behavioural Symptoms of Alzheimer’s Disease
- (2008) Paul T. Francis Neurodegenerative Diseases
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started